Abstract
PDE4 inhibition reduces sputum eosinophils in those COPD patients with higher eosinophil counts. This evidence supports an effect of PDE4 inhibitors on eosinophilic inflammation. https://bit.ly/3airXw7
Trial registration:
ClinicalTrials.gov NCT03004417.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Inhalation
-
Eosinophils*
-
Humans
-
Leukocyte Count
-
Pulmonary Disease, Chronic Obstructive* / drug therapy
-
Sputum
Associated data
-
ClinicalTrials.gov/NCT03004417
-
EudraCT/2015-005550-35